Analisis Eva (Economic Value Added) Untuk Menilai Kinerja Keuangan Perusahaan (Studi Pada Perusahaan Farmasi Pada Bursa Efek Indonesia Periode 2010-2012)

Abstract

This study aimed to explain the financial performance of the company based on the analysis EVA (Economic Value Added). This research is descriptive study with a quantitative approach. The data used are secondary data, obtained from BEI corner and www.idx.co.id site. The selection of the sample using judgement sampling method. This study is using sample from 5 pharmacy companies listed on the Stock Exchange 2010-2012. The data analysis starts form calculation of cost of capital, cost of share, capital structure, Net Operating Profit After Taxes, Weighted Avarage Cost of Capital and the last EVA. The results of this study showed the negative value of EVA only 3 pharmacy companies PT.Kimia Farma (Persero), Tbk Rp.-19.923.733.488,0 (2010), PT.Kalbe Farma, Tbk Rp.-1.186.067.008.010,008 (2010), PT. Pyridam Farma, Tbk Rp.-4.782.389.278. The value of dividend per share and interest expense from the companies being important factors in determining the EVA